Measuring Splicing Disorders in Cancer
Author Information
Author(s): William Ritchie, Samuel Granjeaud, Denis Puthier, Daniel Gautheret
Primary Institution: Université de la Méditerranée, INSERM ERM 206, Technologies Avancées pour le Génome et la Clinique, Marseille, France
Hypothesis
The study aims to evaluate the extent and modalities of non-specific alternative transcript disruptions in cancer.
Conclusion
The expression of normal splice variants is widely and significantly disrupted in at least half of the cancers studied.
Supporting Evidence
- The study found significant entropy gains in alternative splicing for 13 of the 27 cancers studied.
- Normal tissues did not show significantly higher entropy than disease tissues in any of the 27 cases.
- The observed gain in entropy was not attributable to sampling differences in normal and cancer libraries.
Takeaway
Cancer cells often mix up their genetic instructions, leading to mistakes in how they make proteins, which can be measured using a special method called entropy.
Methodology
The study analyzed isoform expression entropy in normal and cancer tissues using Shannon's entropy to measure disorder.
Potential Biases
Potential bias in the selection of cancer tissues and transcript data sources.
Limitations
The study focused only on specific types of transcript variations and may not capture all aspects of splicing disorders.
Participant Demographics
Cancer tissues from 27 different types of cancers were analyzed.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website